Results for crossover translation from Maltese to English

fi studju double- blind u crossover,
when used in subcutaneous infusion pumps, treatment with insulin lispro has been shown to result in lower glycosylated haemoglobin levels compared to soluble insulin.

analiżi os ma ġietx aġġustata għall-effetti potenzjalment li jfixlu lil dak li jkun tal-crossover.
os analysis was not adjusted for the potentially confounding effects of crossover.

f’ pazjenti li nqalbu b’ mod arbitrarju fuq liprolog mix25 fl- ewwel perijodu ta ’ crossover
the first crossover period

2 f’pazjenti li nqalbu b’mod arbitrarju fuq humalog mix25 fl-ewwel perijodu ta’ crossover
2 in patients randomised to humalog mix25 during the first crossover period

dejta ta’ Ġimgħa 98 għal impact jinkludi plaċebo kombinat crossover u pazjenti fuq infliximab li daħlu għall-estensjoni open-label
week 98 data for impact includes combined placebo crossover and infliximab patients who entered the open-label extension

fi studji crossover ta ’ aerius lajofiliżejt li jittieħed mill- ħalq ma ’ aerius pilloli, il- formulazzjonijiet kienu bijoekwivalenti.
in single-dose crossover studies of aerius oral lyophilisate with aerius tablets, the formulations were bioequivalent.

l-os medjan ma ntlaħaqx la għall-grupp ta’ lenvatinib u lanqas għall-grupp tal-plaċebo crossover.
the median os had not been reached for either the lenvatinib group or the placebo crossover group.

fi studju open- label, single- dose, two- treatment, crossover f’ voluntiera f’ saħħithom, etanercept mogħti bħala injezzjoni waħdanija ta ’ 50 mg/ ml instab li kien bijoekwivalenti għal żewġ injezzjonijiet simultanji ta ’ 25 mg/ ml.
in an open-label, single-dose, two- treatment, crossover study in healthy volunteers, etanercept administered as a single 50 mg/ ml injection was found to be bioequivalent to two simultaneous injections of 25 mg/ ml.